FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2918372449> ?p ?o ?g. }

• W2918372449 endingPage "615" @default.
• W2918372449 startingPage "600" @default.
• W2918372449 abstract "As the first-line regimens for the treatment of advanced gastric cancer, both docetaxel, cisplatin, and 5-fluorouracil (DCF) and epirubicin, cisplatin, and 5-fluorouracil (ECF) regimens are commonly used in clinical practice, but there is still controversy about which is better.To compare the efficacy and safety of DCF and ECF regimens by conducting this meta-analysis.Computer searches in PubMed, EMBASE, Ovid MEDLINE, Science Direct, Web of Science, The Cochrane Library and Scopus were performed to find the clinical studies of all comparisons between DCF and ECF regimens. We used progression-free survival (PFS), overall survival (OS), objective response rate (ORR), disease control rate (DCR), and adverse effects (AEs) as endpoints for analysis.Our meta-analysis included seven qualified studies involving a total of 598 patients. The pooled hazard ratios between the DCF and ECF groups were comparable in PFS (95%CI: 0.58-1.46, P = 0.73), OS (95%CI: 0.65-1.10, P = 0.21), and total AEs (95%CI: 0.93-1.29, P = 0.30). The DCF group was significantly better than the ECF group in terms of ORR (95%CI: 1.13-1.75, P = 0.002) and DCR (95%CI: 1.03-1.41, P = 0.02). However, the incidence rate of grade 3-4 AEs was also greater in the DCF group than in the ECF group (95%CI: 1.16-1.88, P = 0.002), especially for neutropenia and febrile neutropenia.With better ORR and DCR values, the DCF regimen seems to be more suitable for advanced gastric cancer than the ECF regimen. However, the higher rate of AEs in the DCF group still needs to be noticed." @default.
• W2918372449 created "2019-03-11" @default.
• W2918372449 creator A5029642484 @default.
• W2918372449 creator A5034995105 @default.
• W2918372449 creator A5055977368 @default.
• W2918372449 creator A5064907989 @default.
• W2918372449 creator A5073257034 @default.
• W2918372449 creator A5089116680 @default.
• W2918372449 date "2019-03-06" @default.
• W2918372449 modified "2023-09-23" @default.
• W2918372449 title "Docetaxel, cisplatin, and 5-fluorouracil compared with epirubicin, cisplatin, and 5-fluorouracil regimen for advanced gastric cancer: A systematic review and meta-analysis" @default.
• W2918372449 cites W1480729244 @default.
• W2918372449 cites W1483592745 @default.
• W2918372449 cites W1875373156 @default.
• W2918372449 cites W1886285345 @default.
• W2918372449 cites W1975072435 @default.
• W2918372449 cites W1984106927 @default.
• W2918372449 cites W1986215651 @default.
• W2918372449 cites W2027778546 @default.
• W2918372449 cites W2038693293 @default.
• W2918372449 cites W2042647323 @default.
• W2918372449 cites W2059725552 @default.
• W2918372449 cites W2074446473 @default.
• W2918372449 cites W2081763103 @default.
• W2918372449 cites W2086692084 @default.
• W2918372449 cites W2088095316 @default.
• W2918372449 cites W2107840962 @default.
• W2918372449 cites W2109012418 @default.
• W2918372449 cites W2122866527 @default.
• W2918372449 cites W2125575554 @default.
• W2918372449 cites W2132174853 @default.
• W2918372449 cites W2142269050 @default.
• W2918372449 cites W2145390243 @default.
• W2918372449 cites W2146590665 @default.
• W2918372449 cites W2169403306 @default.
• W2918372449 cites W2177986043 @default.
• W2918372449 cites W2251541509 @default.
• W2918372449 cites W2320120236 @default.
• W2918372449 cites W2399359492 @default.
• W2918372449 cites W2524647265 @default.
• W2918372449 cites W2538780230 @default.
• W2918372449 cites W2589277340 @default.
• W2918372449 cites W2601284529 @default.
• W2918372449 cites W2777147237 @default.
• W2918372449 cites W2889646458 @default.
• W2918372449 cites W2891146116 @default.
• W2918372449 cites W2991792334 @default.
• W2918372449 cites W4294215472 @default.
• W2918372449 cites W67841682 @default.
• W2918372449 doi "https://doi.org/10.12998/wjcc.v7.i5.600" @default.
• W2918372449 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6406203" @default.
• W2918372449 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30863759" @default.
• W2918372449 hasPublicationYear "2019" @default.
• W2918372449 type Work @default.
• W2918372449 sameAs 2918372449 @default.
• W2918372449 citedByCount "8" @default.
• W2918372449 countsByYear W29183724492020 @default.
• W2918372449 countsByYear W29183724492021 @default.
• W2918372449 countsByYear W29183724492022 @default.
• W2918372449 countsByYear W29183724492023 @default.
• W2918372449 crossrefType "journal-article" @default.
• W2918372449 hasAuthorship W2918372449A5029642484 @default.
• W2918372449 hasAuthorship W2918372449A5034995105 @default.
• W2918372449 hasAuthorship W2918372449A5055977368 @default.
• W2918372449 hasAuthorship W2918372449A5064907989 @default.
• W2918372449 hasAuthorship W2918372449A5073257034 @default.
• W2918372449 hasAuthorship W2918372449A5089116680 @default.
• W2918372449 hasBestOaLocation W29183724491 @default.
• W2918372449 hasConcept C121608353 @default.
• W2918372449 hasConcept C126322002 @default.
• W2918372449 hasConcept C143998085 @default.
• W2918372449 hasConcept C207103383 @default.
• W2918372449 hasConcept C2776478404 @default.
• W2918372449 hasConcept C2776694085 @default.
• W2918372449 hasConcept C2777063308 @default.
• W2918372449 hasConcept C2778850193 @default.
• W2918372449 hasConcept C2780456651 @default.
• W2918372449 hasConcept C2780835546 @default.
• W2918372449 hasConcept C2781190966 @default.
• W2918372449 hasConcept C2781413609 @default.
• W2918372449 hasConcept C44249647 @default.
• W2918372449 hasConcept C530470458 @default.
• W2918372449 hasConcept C71924100 @default.
• W2918372449 hasConcept C90924648 @default.
• W2918372449 hasConcept C95190672 @default.
• W2918372449 hasConceptScore W2918372449C121608353 @default.
• W2918372449 hasConceptScore W2918372449C126322002 @default.
• W2918372449 hasConceptScore W2918372449C143998085 @default.
• W2918372449 hasConceptScore W2918372449C207103383 @default.
• W2918372449 hasConceptScore W2918372449C2776478404 @default.
• W2918372449 hasConceptScore W2918372449C2776694085 @default.
• W2918372449 hasConceptScore W2918372449C2777063308 @default.
• W2918372449 hasConceptScore W2918372449C2778850193 @default.
• W2918372449 hasConceptScore W2918372449C2780456651 @default.
• W2918372449 hasConceptScore W2918372449C2780835546 @default.
• W2918372449 hasConceptScore W2918372449C2781190966 @default.
• W2918372449 hasConceptScore W2918372449C2781413609 @default.
• W2918372449 hasConceptScore W2918372449C44249647 @default.

• next